Posted 18 January 2018
CellAssure’s ingredients have been clinically proven to:
• Demonstrate Anti-Cancer / Anti-tumor effects
• Provide needed nutrition for cancer patients without adding sugar
• Improve immune system response
• Maintain or increase appetite
• Increase LBM (lean body mass)
• Reduce stress / anxiety and lower cortisol levels
• Provide relief with nausea/vomiting and diarrhea
• Mitigate anemia and improve my liver function
The USA Federal Trade Commission (FTC) has acted against the manufacturer with a stipulated order for permanent injunction that prohibits the company from making any representation for any dietary supplement, food, or drug of treating, curing, mitigating, or preventing any disease; symptom of cancer; and side effect, condition, or ailment resulting from cancer treatment. The FTC’s complaint alleged deceptive advertising of two CellMark products: (1) CellAssure, which is marketed as having “anti-cancer and anti-tumor properties” and as a medical breakthrough solution for cancer-related malnutrition; and (2) Cognify, which the company promoted for patients receiving chemotherapy as “the world’s first product designed specifically to alleviate…chemo fog.”
This was in response to a complaint for permanent injunction and other equitable relief by the Federal Trade Commission (FTC).
Interestingly, the company importing the product, Medford, does not make these claims.
Source: Marketers barred from making deceptive claims about products’ ability to mitigate side effects of cancer treatment: CellMark and its CEO lacked scientific evidence to back up their products’ claims. FTC news release, Jan 11, 2018